2015年4月2日讯/生物谷BIOON/--近日，强生旗下医疗器械公司与互联网技术巨头谷歌签订了合作协议，主要用于研发新一代手术机器人，这无论是对医生、病人还是医疗机构而言都是好消息。
制药巨头和互联网大佬之间的合作将会产生怎样的火花呢？两家公司在一份联合声明中表示，二者会联合各自的研发能力、知识产权和专业技术，创造一个全新的机器人协助式手术平台，将先进的技术与医疗充分整合。
这项合作由强生的创新团队促成，而其中财务上的细节并未披露。
机器人协助手术是一类微创手术，旨在运用机械帮助实现手术过程中的精准控制，可以最大限度地减少创伤，以及加速术后恢复。
目前两家公司正在为外科医生和手术室研发新型的机械工具和性能，希望能够融合一流的医疗器械技术和前沿的机器人、成像和数据分析系统。
强生的全球手术团队负责人Gary Pruden表示，在过去的60年中，Ethicon都在致力于研发新产品和技术，与谷歌的合作是强生推进外科诊疗技术非常关键的一步。强生和谷歌都将致力于把科学、技术和外科学充分融合，打造一个世界一流的技术团队。整个合作交易将于今年第二季度完成。
谷歌涉足到生命医学领域已经不是新鲜事了。去年，一项名为“Google X”的谷歌生命科学计划拉开帷幕，主要项目是基因组数据和纳米诊断，由美国国家基因组学研究所的联合创始人Andrew Conrad领导。
2013年，谷歌就曾组建了名为Calico的医疗事业部，由Genentech 前董事长、首席执行官，苹果现任董事长Arthur Levinson领导。
谷歌目前正在寻求解决老龄化问题的方法，除了研发新设备以外，甚至还参与新药的研发。
原文 Google and J&J team up for robotic surgery
Johnson & Johnson's medical device subsidiary Ethicon has signed a deal with technology giant Google to develop new surgical robotics to benefit surgeons， patients and healthcare systems.
In a joint statement the two companies said they would bring together capabilities， intellectual property and expertise to create an “innovative robotic-assisted surgical platform capable of integrating advanced technologies with the goal of improving health care delivery in the operating room”.？
The collaboration was facilitated by？Johnson & Johnson's Innovation group in California - financial details have not been disclosed.
Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons greater control， access and accuracy during the surgical procedure while benefitting patients by minimising trauma and scarring， enabling accelerated post-surgical healing.？
The companies are seeking to develop new robotic tools and capabilities for surgeons and operating room professionals that integrate best-in-class medical device technology with leading-edge robotic systems， imaging and data analytics.
Gary Pruden， worldwide chairman and global surgery group at Johnson & Johnson， said： “For more than 60 years，？Ethicon？has developed products and technologies that have transformed the way surgery is done.
“This collaboration with Google is another important step in our commitment to advancing surgical care， and together， we aim to put the best science， technology and surgical know-how in the hands of medical teams around the world.”
The transaction is expected to close during the second quarter of 2015.？
The life sciences part of the so-called 'Google X' research lab？last year unveiled projects in genomic data？and nano-diagnostics led by Andrew Conrad， a co-founder of the National Genomics Institute.
In 2013 Google also launched its healthcare division？Calico - an abbreviation for the 'California Life Company'？-？which is being led and invested in by Arthur Levinson， chairman and former chief executive of Genentech and current chairman of Google's rival internet firm Apple. ？
The firm is looking to counteract the affects of ageing and also help develop new devices and even medicines to help across a variety of conditions.？